Stefania Simou

618 total citations
13 papers, 369 citations indexed

About

Stefania Simou is a scholar working on Epidemiology, Molecular Biology and Rheumatology. According to data from OpenAlex, Stefania Simou has authored 13 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 4 papers in Molecular Biology and 4 papers in Rheumatology. Recurrent topics in Stefania Simou's work include Inflammatory Myopathies and Dermatomyositis (12 papers), Muscle Physiology and Disorders (4 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). Stefania Simou is often cited by papers focused on Inflammatory Myopathies and Dermatomyositis (12 papers), Muscle Physiology and Disorders (4 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). Stefania Simou collaborates with scholars based in United Kingdom, India and Netherlands. Stefania Simou's co-authors include Lucy R. Wedderburn, Neil McHugh, Sarah Tansley, Clarissa Pilkington, Zoë Betteridge, Claire T. Deakin, Thomas S. Jacques, Raquel Campanilho‐Marques, Wendy Thomson and Michael W. Beresford and has published in prestigious journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and Arthritis Research & Therapy.

In The Last Decade

Stefania Simou

13 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stefania Simou United Kingdom	7	353	231	100	77	62	13	369
Tamara O. Fedczyna United States	6	245 0.7×	172 0.7×	99 1.0×	75 1.0×	29 0.5×	7	323
Peter K. Gregersen United States	7	176 0.5×	162 0.7×	189 1.9×	87 1.1×	83 1.3×	8	442
Cassie Parks United States	5	372 1.1×	168 0.7×	96 1.0×	91 1.2×	32 0.5×	6	406
Damien Amelin France	5	372 1.1×	149 0.6×	84 0.8×	134 1.7×	19 0.3×	9	433
Jean‐Baptiste Vulsteke Belgium	10	229 0.6×	112 0.5×	81 0.8×	57 0.7×	16 0.3×	20	319
Valérie Leclair Canada	11	306 0.9×	86 0.4×	58 0.6×	80 1.0×	23 0.4×	24	340
M. F. G. van der Meulen Netherlands	8	266 0.8×	120 0.5×	38 0.4×	86 1.1×	28 0.5×	9	301
Hidemitsu Orito Japan	6	290 0.8×	207 0.9×	55 0.6×	54 0.7×	31 0.5×	8	372
I. M. Bronner Netherlands	6	224 0.6×	99 0.4×	30 0.3×	70 0.9×	24 0.4×	8	256
Beverley Almeida United Kingdom	5	166 0.5×	121 0.5×	43 0.4×	40 0.5×	30 0.5×	13	199

Countries citing papers authored by Stefania Simou

Since Specialization

Citations

This map shows the geographic impact of Stefania Simou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefania Simou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefania Simou more than expected).

Fields of papers citing papers by Stefania Simou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefania Simou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefania Simou. The network helps show where Stefania Simou may publish in the future.

Co-authorship network of co-authors of Stefania Simou

This figure shows the co-authorship network connecting the top 25 collaborators of Stefania Simou. A scholar is included among the top collaborators of Stefania Simou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefania Simou. Stefania Simou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Simou, Stefania, et al.. (2024). EPH114 Facilitating Real-World Data Discoverability and Transparency of Real-World Evidence to Support Research and Regulatory Decision-Making: The HMA-EMA Real-World Data Catalogues of Data Sources and Studies. Value in Health. 27(12). S243–S243. 1 indexed citations

Boros, C., et al.. (2022). Juvenile Dermatomyositis: what comes next? Long-term outcomes in childhood myositis from a patient perspective. Pediatric Rheumatology. 20(1). 102–102. 6 indexed citations

Campanilho‐Marques, Raquel, Claire T. Deakin, Stefania Simou, et al.. (2020). Retrospective analysis of infliximab and adalimumab treatment in a large cohort of juvenile dermatomyositis patients. Arthritis Research & Therapy. 22(1). 79–79. 33 indexed citations

Yasin, Shireena A., Peter W. Schütz, Claire T. Deakin, et al.. (2018). Histological heterogeneity in a large clinical cohort of juvenile idiopathic inflammatory myopathy: analysis by myositis autoantibody and pathological features. Neuropathology and Applied Neurobiology. 45(5). 495–512. 33 indexed citations

Deakin, Claire T., Raquel Campanilho‐Marques, Stefania Simou, et al.. (2018). Efficacy and Safety of Cyclophosphamide Treatment in Severe Juvenile Dermatomyositis Shown by Marginal Structural Modeling. Arthritis & Rheumatology. 70(5). 785–793. 39 indexed citations

Tansley, Sarah, Stefania Simou, Gavin Shaddick, et al.. (2017). Autoantibodies in juvenile-onset myositis: Their diagnostic value and associated clinical phenotype in a large UK cohort. Journal of Autoimmunity. 84. 55–64. 118 indexed citations

Almeida, Beverley, Sarah Tansley, Stefania Simou, et al.. (2017). 17. Anti-synthetase autoantibody is seen in patients with overlap myositis in the UK cohort of patients with Jveunile Dermatomyositis. Lara D. Veeken. 56(suppl_7). 1 indexed citations

Almeida, Beverley, Sarah Tansley, Stefania Simou, et al.. (2017). 053. ANTI-SYNTHETASE AUTOANTIBODY IS SEEN IN PATIENTS WITH OVERLAP MYOSITIS IN THE UK COHORT OF PATIENTS WITH JUVENILE DERMATOMYOSITIS. Lara D. Veeken. 56(suppl_2). 1 indexed citations

Tansley, Sarah, Zoë Betteridge, Stefania Simou, et al.. (2017). Anti-HMGCR Autoantibodies in Juvenile Idiopathic Inflammatory Myopathies Identify a Rare but Clinically Important Subset of Patients. The Journal of Rheumatology. 44(4). 488–492. 53 indexed citations

10.

McCann, Liza, et al.. (2016). Juvenile Dermatomyositis: What Comes Next?. UCL Discovery (University College London). 2 indexed citations

11.

Tansley, Sarah, Zoë Betteridge, Stefania Simou, et al.. (2016). 174 A Diagnostic and Treatment Challenge: The Prevalence and Clinical Associations of Anti-HMG-CoA Reductase Autoantibodies in a Large UK Juvenile-Onset Myositis Cohort. Lara D. Veeken. 55(suppl_1). i132–i133. 2 indexed citations

12.

Deakin, Claire T., Shireena A. Yasin, Stefania Simou, et al.. (2016). Muscle Biopsy Findings in Combination With Myositis‐Specific Autoantibodies Aid Prediction of Outcomes in Juvenile Dermatomyositis. Arthritis & Rheumatology. 68(11). 2806–2816. 76 indexed citations

13.

Campanilho‐Marques, Raquel, Claire T. Deakin, Stefania Simou, Lucy R. Wedderburn, & Clarissa Pilkington. (2016). OP0221 Efficacy and Safety of Tumour Necrosis Factor-Alpha Antagonists in A Large Cohort of Juvenile Dermatomyositis Patients. Annals of the Rheumatic Diseases. 75. 140–141. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact